Lobectomy vs total thyroidectomy for unilateral papillary thyroid carcinoma with ipsilateral cervical lymph node metastasis

ObjectiveThis study aimed to compare the prognosis of unilateral papillary thyroid carcinoma(PTC) patients with ipsilateral cervical lymph node metastasis(IC-LNM) under the treatment of unilateral lobectomy(uLT) vs total thyroidectomy(TT) in order to find out the optimal surgery for these patients w...

Full description

Saved in:
Bibliographic Details
Main Authors: Shijia Zhang, Kehui Zhou, Jinyu Wang, Ming Zhao, Xiaochun Mao, Jinbiao Shang, Xiabin Lan
Format: Article
Language:English
Published: Frontiers Media S.A. 2025-07-01
Series:Frontiers in Endocrinology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fendo.2025.1564752/full
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1839618415889743872
author Shijia Zhang
Shijia Zhang
Kehui Zhou
Kehui Zhou
Jinyu Wang
Ming Zhao
Xiaochun Mao
Jinbiao Shang
Xiabin Lan
Xiabin Lan
author_facet Shijia Zhang
Shijia Zhang
Kehui Zhou
Kehui Zhou
Jinyu Wang
Ming Zhao
Xiaochun Mao
Jinbiao Shang
Xiabin Lan
Xiabin Lan
author_sort Shijia Zhang
collection DOAJ
description ObjectiveThis study aimed to compare the prognosis of unilateral papillary thyroid carcinoma(PTC) patients with ipsilateral cervical lymph node metastasis(IC-LNM) under the treatment of unilateral lobectomy(uLT) vs total thyroidectomy(TT) in order to find out the optimal surgery for these patients without other clinical risk characteristics.MethodsPTC patients at Zhejiang Cancer Hospital between 2012 and 2022 were retrospectively reviewed. Additionally, a propensity score matching(PSM) was performed on patients treated with uLT or TT. Recurrence-free survival(RFS), overall survival(OS), hospitalization costs, postoperative complications, and other clinical characteristics were analyzed between the two groups.ResultsUltimately, 682 unilateral PTC patients with IC-LNM were available in the study. After PSM with possible prognostic factors(such as gender, age, primary tumor size, multifocality, extrathyroidal invasion, and T-stage), 225 pairs of patients were available. With a median of 81(5-154) months follow-up, 22 patients(9.8%) in the uLT and 12(5.3%) in the TT recurred. There were no significant differences in 5-year RFS and 5-year OS between uLT and TT groups. However, TT group was significantly correlated with higher risk of transient and permanent hypoparathyroidism, higher levothyroxine doses, longer hospital stays, and higher hospitalization costs than uLT group(p<0.05).ConclusionsOur study indicated that there were no differences in recurrence and survival between unilateral PTC patients with IC-LNM treated with uLT or TT for the primary tumor. However, uLT group had a lower risk of postoperative complications and a lower hospitalization cost than TT group. Thus, for selected unilateral PTC patients with IC-LNM without other risk features, uLT could be recommended.
format Article
id doaj-art-f0c4e10366724d7f95fccdda29b7f1b6
institution Matheson Library
issn 1664-2392
language English
publishDate 2025-07-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Endocrinology
spelling doaj-art-f0c4e10366724d7f95fccdda29b7f1b62025-07-24T04:10:31ZengFrontiers Media S.A.Frontiers in Endocrinology1664-23922025-07-011610.3389/fendo.2025.15647521564752Lobectomy vs total thyroidectomy for unilateral papillary thyroid carcinoma with ipsilateral cervical lymph node metastasisShijia Zhang0Shijia Zhang1Kehui Zhou2Kehui Zhou3Jinyu Wang4Ming Zhao5Xiaochun Mao6Jinbiao Shang7Xiabin Lan8Xiabin Lan9Department of Thyroid Surgery, Zhejiang Cancer Hospital, Hangzhou Institute of Medicine (HIM), Chinese Academy of Sciences, Hangzhou, Zhejiang, ChinaPostgraduate Training Base Alliance of Wenzhou Medical University (Zhejiang Cancer Hospital), Hangzhou, Zhejiang, ChinaDepartment of Thyroid Surgery, Zhejiang Cancer Hospital, Hangzhou Institute of Medicine (HIM), Chinese Academy of Sciences, Hangzhou, Zhejiang, ChinaPostgraduate Training Base Alliance of Wenzhou Medical University (Zhejiang Cancer Hospital), Hangzhou, Zhejiang, ChinaDepartment of Medical Records and Statistics, Zhejiang Cancer Hospital, Hangzhou Institute of Medicine (HIM), Chinese Academy of Sciences, Hangzhou, Zhejiang, ChinaDepartment of Thyroid Surgery, Zhejiang Cancer Hospital, Hangzhou Institute of Medicine (HIM), Chinese Academy of Sciences, Hangzhou, Zhejiang, ChinaDepartment of Thyroid Surgery, Zhejiang Cancer Hospital, Hangzhou Institute of Medicine (HIM), Chinese Academy of Sciences, Hangzhou, Zhejiang, ChinaDepartment of Thyroid Surgery, Zhejiang Cancer Hospital, Hangzhou Institute of Medicine (HIM), Chinese Academy of Sciences, Hangzhou, Zhejiang, ChinaDepartment of Thyroid Surgery, Zhejiang Cancer Hospital, Hangzhou Institute of Medicine (HIM), Chinese Academy of Sciences, Hangzhou, Zhejiang, ChinaPostgraduate Training Base Alliance of Wenzhou Medical University (Zhejiang Cancer Hospital), Hangzhou, Zhejiang, ChinaObjectiveThis study aimed to compare the prognosis of unilateral papillary thyroid carcinoma(PTC) patients with ipsilateral cervical lymph node metastasis(IC-LNM) under the treatment of unilateral lobectomy(uLT) vs total thyroidectomy(TT) in order to find out the optimal surgery for these patients without other clinical risk characteristics.MethodsPTC patients at Zhejiang Cancer Hospital between 2012 and 2022 were retrospectively reviewed. Additionally, a propensity score matching(PSM) was performed on patients treated with uLT or TT. Recurrence-free survival(RFS), overall survival(OS), hospitalization costs, postoperative complications, and other clinical characteristics were analyzed between the two groups.ResultsUltimately, 682 unilateral PTC patients with IC-LNM were available in the study. After PSM with possible prognostic factors(such as gender, age, primary tumor size, multifocality, extrathyroidal invasion, and T-stage), 225 pairs of patients were available. With a median of 81(5-154) months follow-up, 22 patients(9.8%) in the uLT and 12(5.3%) in the TT recurred. There were no significant differences in 5-year RFS and 5-year OS between uLT and TT groups. However, TT group was significantly correlated with higher risk of transient and permanent hypoparathyroidism, higher levothyroxine doses, longer hospital stays, and higher hospitalization costs than uLT group(p<0.05).ConclusionsOur study indicated that there were no differences in recurrence and survival between unilateral PTC patients with IC-LNM treated with uLT or TT for the primary tumor. However, uLT group had a lower risk of postoperative complications and a lower hospitalization cost than TT group. Thus, for selected unilateral PTC patients with IC-LNM without other risk features, uLT could be recommended.https://www.frontiersin.org/articles/10.3389/fendo.2025.1564752/fullunilateral lobectomytotal thyroidectomypapillary thyroid carcinomarecurrence-free survivalpropensity score matching
spellingShingle Shijia Zhang
Shijia Zhang
Kehui Zhou
Kehui Zhou
Jinyu Wang
Ming Zhao
Xiaochun Mao
Jinbiao Shang
Xiabin Lan
Xiabin Lan
Lobectomy vs total thyroidectomy for unilateral papillary thyroid carcinoma with ipsilateral cervical lymph node metastasis
Frontiers in Endocrinology
unilateral lobectomy
total thyroidectomy
papillary thyroid carcinoma
recurrence-free survival
propensity score matching
title Lobectomy vs total thyroidectomy for unilateral papillary thyroid carcinoma with ipsilateral cervical lymph node metastasis
title_full Lobectomy vs total thyroidectomy for unilateral papillary thyroid carcinoma with ipsilateral cervical lymph node metastasis
title_fullStr Lobectomy vs total thyroidectomy for unilateral papillary thyroid carcinoma with ipsilateral cervical lymph node metastasis
title_full_unstemmed Lobectomy vs total thyroidectomy for unilateral papillary thyroid carcinoma with ipsilateral cervical lymph node metastasis
title_short Lobectomy vs total thyroidectomy for unilateral papillary thyroid carcinoma with ipsilateral cervical lymph node metastasis
title_sort lobectomy vs total thyroidectomy for unilateral papillary thyroid carcinoma with ipsilateral cervical lymph node metastasis
topic unilateral lobectomy
total thyroidectomy
papillary thyroid carcinoma
recurrence-free survival
propensity score matching
url https://www.frontiersin.org/articles/10.3389/fendo.2025.1564752/full
work_keys_str_mv AT shijiazhang lobectomyvstotalthyroidectomyforunilateralpapillarythyroidcarcinomawithipsilateralcervicallymphnodemetastasis
AT shijiazhang lobectomyvstotalthyroidectomyforunilateralpapillarythyroidcarcinomawithipsilateralcervicallymphnodemetastasis
AT kehuizhou lobectomyvstotalthyroidectomyforunilateralpapillarythyroidcarcinomawithipsilateralcervicallymphnodemetastasis
AT kehuizhou lobectomyvstotalthyroidectomyforunilateralpapillarythyroidcarcinomawithipsilateralcervicallymphnodemetastasis
AT jinyuwang lobectomyvstotalthyroidectomyforunilateralpapillarythyroidcarcinomawithipsilateralcervicallymphnodemetastasis
AT mingzhao lobectomyvstotalthyroidectomyforunilateralpapillarythyroidcarcinomawithipsilateralcervicallymphnodemetastasis
AT xiaochunmao lobectomyvstotalthyroidectomyforunilateralpapillarythyroidcarcinomawithipsilateralcervicallymphnodemetastasis
AT jinbiaoshang lobectomyvstotalthyroidectomyforunilateralpapillarythyroidcarcinomawithipsilateralcervicallymphnodemetastasis
AT xiabinlan lobectomyvstotalthyroidectomyforunilateralpapillarythyroidcarcinomawithipsilateralcervicallymphnodemetastasis
AT xiabinlan lobectomyvstotalthyroidectomyforunilateralpapillarythyroidcarcinomawithipsilateralcervicallymphnodemetastasis